MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF), a pharmaceutical company specialized in cannabis, has announced that McMaster University, a partner of the company, has been given permission by Health to conduct a clinical trial using some of MediPharm’s cannabinoid formulations.

MediPharm called the decision “a key milestone in moving forward with the Company’s strategy to be the go-to cannabis partner for pharmaceuticals containing cannabis.”

A phase 2, double-blind, randomized, placebo-controlled trial will evaluate the efficacy and safety …

Full story available on Benzinga.com

More MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia